PMA device
SURGICELTM POWDER Absorbable Hemostatic Powder
ETHICON, Inc. · Agent, Absorbable Hemostatic, Non-Collagen Based (LMG, Class III) · First FDA decision Jul 28, 2026, newest Jul 28, 2026Surgical bleeding and hemostasis
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
PMA pathway
Device trials
0
Naming "SURGICELTM POWDER"
MAUDE reports
0
Brand "SURGICELTM POWDER", since 2015
PubMed studies
0
Mentioning "SURGICELTM POWDER"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing SURGICELTM POWDER Absorbable Hemostatic Powder
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- SURGICELTM POWDER Absorbable Hemostatic PowderPMA supplement
N12159-S129 · Decided Jul 28, 2026 · 144 days after receipt · Normal 180 Day Track
Device type: Agent, absorbable hemostatic, non-collagen based (LMG) · General & Plastic Surgery
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "SURGICELTM POWDER", any status and sponsor, newest update first.
No registered device study names "SURGICELTM POWDER".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "SURGICELTM POWDER", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code LMG
1,626 reports: 410 malfunction, 1,192 injury, 23 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "SURGICELTM POWDER"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code LMG.
- Arista AH Absorbable Hemostatic ParticlesDavol, Inc. · PMA 2021
- PerClot® Polysaccharide Hemostatic SystemBaxter Healthcare Corporation · PMA 2026
- SURGICEL Endoscopic ApplicatorETHICON, Inc. · PMA 2018
- Surgicel / Surgicel Nu-Knit / Surgicel Fibrillar Absorbable HemostatETHICON, Inc. · PMA 2005
- Surgicel Powder Absorbable Hemostatic PowderETHICON, Inc. · PMA 2017
- Arista Ah, Arista Ah Flexitip/ Flexitip Xl/ Flexitip Xl-RDavol, Inc. · PMA 2015
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.